Merck refiles $11.5B Acceleron deal with the FTC. But extending regulators' review time only one benefit | Fierce Pharma
Merck pulls Keytruda's FDA nod for third-line stomach cancer | pharmaphorum
Merck pulls plug on two potential COVID vaccines | Drugs News | Al Jazeera
New Covid Antiviral Pills Offer Hope as Omicron Looms - The New York Times
Merck-Launches-Alzheimers-Trial
Merck & Co pulls out of hepatitis C R&D as market shrinks - PMLiVE
8 lingering questions about the new Covid pills from Merck and Pfizer
Gardasil pulls in $1.5bn, driving vaccines for Merck - BioProcess InsiderBioProcess International
What we know — and don't know — about Merck's new Covid-19 pill
FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited
Merck Pulls Out Of Agreement To Supply Life-Saving Rotavirus Vaccine To Millions Of Kids : Goats and Soda : NPR
Merck & Co - Drug Company History, Products & Lawsuits
Merck will allow drugmakers in other countries to make COVID pill : Coronavirus Updates : NPR
Merck's (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says - Bloomberg
FDA tells Merck to show more data for its OncoImmune COVID-19 drug as EUA pushed back | Fierce Biotech
Merck Pulls Keytruda for SCLC | LCFA
Merck pauses Russia investments, to supply essential medicines | Reuters
Merck pulls out of license deal with Ono Pharma for MS drug ceralifimo
Merck's Covid Treatment Pill: What to Know About Molnupiravir - The New York Times
New COVID-19 pills may keep recently diagnosed patients out of hospital, company says - ABC News
